Document is current
Any future updates will be listed below
-
Authors
Doi, Toshihiko
Shitara, Kohei
Kojima, Takashi
Yoshino, Takayuki
Dontabhaktuni, Aruna
Rebscher, Hans
Tang, Shande
Cosaert, Jan
Ohtsu, Atsushi
-
Funding
Funding for this research was provided by:
Eli Lilly and Company
- License Information
-
More Information
Article History
Received: 6 January 2016
Accepted: 19 April 2016
First Online: 30 April 2016
Compliance with ethical standards
:
: Atsushi Ohtsu, Kohei Shitara, Takashi Komjima, and Toshihiko Doi have nothing to disclose. Takayuki Yoshino received research funding from Dainippon Sumitomo Pharma. Jan Cosaert was an employee of Eli Lilly and Company during the conduct of the study. Aruna Dontabhaktuni was an employee of Eli Lilly and Company during the conduct of the study and reports renumeration and stock ownership in Eli Lilly and Company. Hans Rebscher and Shande Tang are employees of Eli Lilly and Company; Shande Tang reports stock ownership in Eli Lilly and Company.
